Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grana

Showing results (531-540 of 603) with videos related to

Pageof 61
Sort By:
Journal of Neurophysiology|April 4, 2019
Hair cell and neural contributions to the cochlear summating potentialAndrew K Pappa, Kendall A Hutson, William C Scott, et al.
Tumori|August 1, 2020
Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapyDario Zerini, Filippo Patti, Francesca Spada, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Interim <sup>18</sup>FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic reviewMahila Ferrari, Laura Lavinia Travaini, Delia Ciardo, et al.
Cancer Treatment Reviews|March 18, 2017
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectivesIoana Lambrescu, Simona Fica, Diana Martins, et al.
Endocrine|February 7, 2024
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2017
Role of interim <sup>18</sup>F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic reviewMarta Cremonesi, Laura Gilardi, Mahila Esmeralda Ferrari, et al.
Journal of Neuroendocrinology|April 14, 2026
The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [<sup>177</sup>Lu]Lu-DOTA-TATE: A post-authorisation safety studyJohannes Hofland, Chiara Maria Grana, Martin O Weickert, et al.
Pain Medicine (Malden, Mass.)|March 22, 2021
Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans AffairsMark Bounthavong, Marcos K Lau, Chad L Kay, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart diseaseGiulia Renda, Stefania Tacconelli, Marta L Capone, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.
Pageof 61

Showing results (531-540 of 603) with videos related to

Sort By:
Pageof 61
Journal of Neurophysiology|April 4, 2019
Hair cell and neural contributions to the cochlear summating potentialAndrew K Pappa, Kendall A Hutson, William C Scott, et al.
Tumori|August 1, 2020
Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapyDario Zerini, Filippo Patti, Francesca Spada, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Interim <sup>18</sup>FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic reviewMahila Ferrari, Laura Lavinia Travaini, Delia Ciardo, et al.
Cancer Treatment Reviews|March 18, 2017
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectivesIoana Lambrescu, Simona Fica, Diana Martins, et al.
Endocrine|February 7, 2024
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2017
Role of interim <sup>18</sup>F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic reviewMarta Cremonesi, Laura Gilardi, Mahila Esmeralda Ferrari, et al.
Journal of Neuroendocrinology|April 14, 2026
The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [<sup>177</sup>Lu]Lu-DOTA-TATE: A post-authorisation safety studyJohannes Hofland, Chiara Maria Grana, Martin O Weickert, et al.
Pain Medicine (Malden, Mass.)|March 22, 2021
Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans AffairsMark Bounthavong, Marcos K Lau, Chad L Kay, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart diseaseGiulia Renda, Stefania Tacconelli, Marta L Capone, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.
Pageof 61